ASPECTS OF THE STRUCTURE OF THE D2 DOPAMINE RECEPTOR

被引:53
|
作者
STRANGE, PG
机构
[1] Biological Laboratory, The University, Canterbury
关键词
D O I
10.1016/0166-2236(90)90022-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Significant new information on the D2 dopamine receptor has recently become available from a combination of protein chemical and molecular genetic analyses. Molecular genetic studies have shown the receptor to be a member of the family of receptors that are linked to G proteins and that have structures predicted to contain seven transmembrane domains. Two distinct species of D2 dopamine receptor have been found which may differ in their coupling to G proteins; their distributions have been mapped at the nucleic acid level. The D2 dopamine receptor has been purified from brain and anterior pituitary and characterized. Chemical modification of the brain receptor provides evidence for the importance of a carboxyl group that interacts with ligands at the receptor binding site. Here, Philip Strange discusses these points and proposes models of receptor-ligand interaction based on the conservation of several aspartic acid residues in receptors that bind cationic amines. © 1990.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 50 条
  • [1] Novel Aspects of the Reversibility of the Antagonism at the Dopamine D2 Receptor by Antipsychotics
    Sahlholm, Kristoffer
    Frisk, Sofia
    Nilsson, Johanna
    Marcellino, Daniel
    Fuxe, Kjell
    Ogren, Sven Ove
    Arhem, Peter
    [J]. BIOPHYSICAL JOURNAL, 2013, 104 (02) : 26A - 26A
  • [2] Dopamine D2 receptor gene polymorphisms and clinical response to dopamine D2 receptor antagonists
    Mihara, K
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S59 - S59
  • [3] Dopamine D2 receptor and obesity
    Chen, JS
    [J]. LANCET, 2001, 357 (9271): : 1883 - +
  • [4] Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
    Im, Dohyun
    Inoue, Asuka
    Fujiwara, Takaaki
    Nakane, Takanori
    Yamanaka, Yasuaki
    Uemura, Tomoko
    Mori, Chihiro
    Shiimura, Yuki
    Kimura, Kanako Terakado
    Asada, Hidetsugu
    Nomura, Norimichi
    Tanaka, Tomoyuki
    Yamashita, Ayumi
    Nango, Eriko
    Tono, Kensuke
    Kadji, Francois Marie Ngako
    Aoki, Junken
    Iwata, So
    Shimamura, Tatsuro
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [5] Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
    Dohyun Im
    Asuka Inoue
    Takaaki Fujiwara
    Takanori Nakane
    Yasuaki Yamanaka
    Tomoko Uemura
    Chihiro Mori
    Yuki Shiimura
    Kanako Terakado Kimura
    Hidetsugu Asada
    Norimichi Nomura
    Tomoyuki Tanaka
    Ayumi Yamashita
    Eriko Nango
    Kensuke Tono
    Francois Marie Ngako Kadji
    Junken Aoki
    So Iwata
    Tatsuro Shimamura
    [J]. Nature Communications, 11
  • [6] Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization
    Wouters, Elise
    Ricarte Marin, Adrian
    Rupert Dalton, James Andrew
    Giraldo, Jesus
    Stove, Christophe
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [7] Bifeprunox:: Dopamine D2 receptor occupancy
    Devries, M
    Grahnen, A
    Bergström, M
    Långström, B
    Olsen, CK
    Brennum, LT
    Kreilgaard, M
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 243S - 244S
  • [8] The regulation of D2 dopamine receptor expression
    R J Hitzemann
    [J]. Molecular Psychiatry, 1998, 3 : 198 - 203
  • [9] Targeting the dopamine D2 receptor in schizophrenia
    Seeman, Philip
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) : 515 - 531
  • [10] PharmGKB summary: dopamine receptor D2
    Mi, Huaiyu
    Thomas, Paul D.
    Ring, Huijun Z.
    Jiang, Ruhong
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    [J]. PHARMACOGENETICS AND GENOMICS, 2011, 21 (06): : 350 - 356